HTA321 Factors Influencing the Shi Costs of Orphan Drugs After Their Renewed Regular Benefit Assessment Due to Exceeding the Sales Threshold in Germany
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.2004
https://www.valueinhealthjournal.com/article/S1098-3015(23)05134-3/fulltext
Title :
HTA321 Factors Influencing the Shi Costs of Orphan Drugs After Their Renewed Regular Benefit Assessment Due to Exceeding the Sales Threshold in Germany
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05134-3&doi=10.1016/j.jval.2023.09.2004
First page :
Section Title :
Open access? :
No
Section Order :
11450